Skip to main content
CODX
NASDAQ Industrial Applications And Services

Co-Diagnostics Activates $7.9M ATM Program Under Existing Shelf, Adding Dilution Overhang

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.04
Mkt Cap
$10.769M
52W Low
$1.26
52W High
$46.5
52W Position info
62% above low
Off High info
96% below high
Rel. Volume
Market data snapshot near publication time

CODX sits 62% above its 52-week low of $1.26.

Summary

Co-Diagnostics activated an at-the-market equity program to sell up to $7.9 million of common stock, providing needed capital but adding dilution risk for a company already facing a going concern warning.


Key Events · Financing and Capital Events · CODX

  • ATM Program Activated

    Co-Diagnostics amended its Equity Distribution Agreement with Maxim to sell up to $7.9 million of common stock through an at-the-market offering under its existing $150 million shelf registration.

  • Dilution Overhang

    Assuming sales at the recent price of $2.10, the offering could add up to 3.76 million shares, increasing the outstanding count by approximately 71% from the 5.28 million shares as of June 30, 2026.

  • Going Concern Context

    The company's auditor has raised substantial doubt about its ability to continue as a going concern, and the prior ATM program had expired, making this new capital-raising avenue critical for operations.

  • Recent Financing History

    This ATM follows a $3.0 million deeply discounted private placement in May 2026 and a proxy seeking approval to expand the equity plan by 2 million shares, indicating ongoing urgent capital needs.


Analysis · CODX · Industrial Applications And Services

To secure a financial lifeline, Co-Diagnostics has amended its existing Equity Distribution Agreement with Maxim, enabling sales under the $150 million shelf registration. The company can now sell up to $7.9 million worth of common stock into the market at prevailing prices. This ATM program arrives as the cash-strapped diagnostics firm faces a going concern warning and recently completed a deeply discounted $3 million private placement. While the capital is critical, the sales will dilute existing shareholders, and the overhang could pressure the stock, which currently trades near $2. The filing follows the S-3 shelf registration from May 2026 and the Q1 2026 report that highlighted critical cash burn and an expired prior ATM.

At the time of this filing, CODX was trading at $2.04 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $10.8M. The 52-week trading range was $1.26 to $46.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CODX - Latest Insights

CODX
Jul 22, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
CODX
Jul 09, 2026, 6:18 PM EDT
Filing Type: PRE 14A
Importance Score:
7
CODX
May 28, 2026, 4:30 PM EDT
Filing Type: S-3
Importance Score:
9
CODX
May 26, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
CODX
May 21, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8